(Q52552043)

3 May 2018

title

Apurinic sites are position-specific topoisomerase II poisons. (English)

1 reference

3 May 2018

0 references

2

Osheroff N

1 reference

3 May 2018

author name string

Kingma PS

series ordinal

1

1 reference

3 May 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

3 May 2018

Journal of Biological Chemistry

published in

1 reference

3 May 2018

volume

272

1 reference

3 May 2018

issue

2

1 reference

3 May 2018

page(s)

1148-1155

1 reference

3 May 2018

Catalytic function of DNA topoisomerase II.

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Structure and function of type II DNA topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Recent developments in DNA topoisomerase II structure and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

When good enzymes go bad: conversion of topoisomerase II to a cellular toxin by antineoplastic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Topoisomerase II enzymes and mutagenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Topoisomerase poisons: harnessing the dark side of enzyme mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

DNA topoisomerases: essential enzymes and lethal targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Topoisomerase inhibitors. A review of their therapeutic potential in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Complete Nucleotide Sequence of the Escherichia coli Plasmid pBR322

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Rapid and efficient site-specific mutagenesis without phenotypic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Effects of antineoplastic drugs on the post-strand-passage DNA cleavage/religation equilibrium of topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

The binding of gyrase to DNA: analysis by retention by nitrocellulose filters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Local sequence requirements for DNA cleavage by mammalian topoisomerase II in the presence of doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Rate of depurination of native deoxyribonucleic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Mutagenesis by apurinic/apyrimidinic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Instability and decay of the primary structure of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Mutational specificity of depurination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Double-stranded DNA cleavage/religation reaction of eukaryotic topoisomerase II: evidence for a nicked DNA intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Strand specificity of the topoisomerase II mediated double-stranded DNA cleavage reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Incomplete reversion of double stranded DNA cleavage mediated by Drosophila topoisomerase II: formation of single stranded DNA cleavage complex in the presence of an anti-tumor drug VM26

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

DNA topoisomerase-trapping antitumour drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Effect of antineoplastic agents on the DNA cleavage/religation reaction of eukaryotic topoisomerase II: inhibition of DNA religation by etoposide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Synthesis and proton-NMR studies of oligonucleotides containing an apurinic (AP) site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Conformational Flexibility in DNA Duplexes Containing Single G . G Mismatches

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Refined solution structure of a DNA heteroduplex containing an aldehydic abasic site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Using yeast to study resistance to topoisomerase II-targeting drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Drug resistance associated with altered DNA topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

DNA topoisomerase II mutations and resistance to anti-tumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Repair of oxidative damage to DNA: enzymology and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

DNA damages processed by base excision repair: biological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Cellular role of yeast Apn1 apurinic endonuclease/3'-diesterase: repair of oxidative and alkylation DNA damage and control of spontaneous mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

A consensus sequence for cleavage by vertebrate DNA topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

The DNA binding, cleavage, and religation reactions of eukaryotic topoisomerases I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Infant leukemia, topoisomerase II inhibitors, and the MLL gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

Helical parameters, fluctuations, alternative hydrogen bonding, and bending in oligonucleotides containing a mistmatched base-pair by NOESY distance restrained and distance free molecular dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

NMR studies of abasic sites in DNA duplexes: deoxyadenosine stacks into the helix opposite the cyclic analogue of 2-deoxyribose

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.2.1148

21 January 2018

Identifiers

DOI

10.1074/JBC.272.2.1148

1 reference

3 May 2018

1 reference

3 May 2018